Future battlefields will be shaped by AI weapons that defense firms and Big Tech are vying to build for the military. Guardrails are lagging.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.
A half dozen humanoid robots completed a half marathon in Beijing, though their prowess still trails human runners by a considerable amount.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.
Banks pocketed huge sums in the first quarter from equities because the “increased market volatility” triggered a rush on transactions.
With Hollywood conquered, Netflix has a new goal: reach a $1 trillion market cap by 2030, according to a Wall Street Journal report.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The technology is garnering interest for its energy-saving benefits.